Jan 10, 2022 / 06:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Zoetis today at the 40th Annual JPMorgan Healthcare Conference. From the company, we have Kristin Peck, CEO; as well as Wetteny Joseph, CFO.
And before I turn it over to Chris, and I do want to remind people that if you have a question to use the Ask A Question feature on the website, and I'll work those into the Q&A after the presentation.
So with that, Kristin, happy new year, thanks for joining us and look forward to the presentation.
Kristin C. Peck - Zoetis Inc. - CEO & Director
Thank you, Chris. It's a pleasure to be speaking with you and the JPMorgan health care audience again this year.
I know we're all a little disappointed not to be in San Francisco, but I want to thank the organizers for being cautious and early and continuing to put people's health first during the pandemic.
So before I talk about how Zoetis is advancing
Zoetis Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers